Next Article in Journal
Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines
Next Article in Special Issue
Cap-Independent Circular mRNA Translation Efficiency
Previous Article in Journal
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes
 
 
Article

Article Versions Notes

Vaccines 2022, 10(12), 2066; https://doi.org/10.3390/vaccines10122066
Action Date Notes Link
article xml file uploaded 1 December 2022 15:22 CET Original file -
article xml uploaded. 1 December 2022 15:22 CET Update https://www.mdpi.com/2076-393X/10/12/2066/xml
article pdf uploaded. 1 December 2022 15:22 CET Version of Record https://www.mdpi.com/2076-393X/10/12/2066/pdf
article html file updated 1 December 2022 15:24 CET Original file -
article html file updated 4 March 2023 00:37 CET Update https://www.mdpi.com/2076-393X/10/12/2066/html
Back to TopTop